Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,171 | 203 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Pharmaceuticals, Inc | $543.01 | 22 | $0 (2024) |
| ITI, Inc. | $504.60 | 22 | $0 (2023) |
| Alkermes, Inc. | $500.04 | 30 | $0 (2024) |
| Neurocrine Biosciences, Inc. | $440.71 | 23 | $0 (2024) |
| Teva Pharmaceuticals USA, Inc. | $424.28 | 19 | $0 (2024) |
| Indivior Inc. | $423.46 | 20 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $357.60 | 17 | $0 (2024) |
| Lundbeck LLC | $259.45 | 14 | $0 (2024) |
| ABBVIE INC. | $246.76 | 13 | $0 (2024) |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $222.49 | 9 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,284 | 61 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) ($222.49) |
| 2023 | $1,500 | 74 | Teva Pharmaceuticals USA, Inc. ($252.42) |
| 2022 | $1,387 | 68 | ITI, Inc. ($285.65) |
All Payment Transactions
203 individual payment records from CMS Open Payments — Page 1 of 9
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | E.R. Squibb & Sons, L.L.C. | COBENFY (Drug) | Food and Beverage | Cash or cash equivalent | $14.07 | General |
| Category: Psychiatry/Psychology | ||||||
| 12/12/2024 | Otsuka America Pharmaceutical, Inc. | ABILIFY ASIMTUFII (Drug) | Food and Beverage | In-kind items and services | $25.24 | General |
| Category: PSYCHIATRY | ||||||
| 12/05/2024 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $16.88 | General |
| Category: CNS | ||||||
| 12/05/2024 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $4.37 | General |
| Category: CNS | ||||||
| 12/04/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $26.39 | General |
| Category: PSYCHIATRY | ||||||
| 11/27/2024 | Vanda Pharmaceuticals Inc. | FANAPT (Drug) | Food and Beverage | In-kind items and services | $28.31 | General |
| Category: SCHIZOPHRENIA | ||||||
| 11/21/2024 | Alkermes, Inc. | VIVITROL (Drug) | Food and Beverage | In-kind items and services | $28.82 | General |
| Category: CNS | ||||||
| 11/21/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $11.94 | General |
| Category: NEUROSCIENCE | ||||||
| 11/14/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $15.35 | General |
| Category: Neuropsychiatry | ||||||
| 11/13/2024 | Otsuka America Pharmaceutical, Inc. | ABILIFY ASIMTUFII (Drug) | Food and Beverage | In-kind items and services | $14.28 | General |
| Category: PSYCHIATRY | ||||||
| 11/07/2024 | Vanda Pharmaceuticals Inc. | FANAPT (Drug) | Food and Beverage | In-kind items and services | $21.28 | General |
| Category: SCHIZOPHRENIA | ||||||
| 10/23/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $21.83 | General |
| Category: PSYCHIATRY | ||||||
| 10/21/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $19.49 | General |
| Category: PSYCHIATRY | ||||||
| 10/17/2024 | Alkermes, Inc. | VIVITROL (Drug) | Food and Beverage | In-kind items and services | $18.33 | General |
| Category: CNS | ||||||
| 10/09/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $6.01 | General |
| Category: NEUROSCIENCE | ||||||
| 10/08/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $16.66 | General |
| Category: Neuropsychiatry | ||||||
| 10/03/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $33.46 | General |
| Category: Neuropsychiatry | ||||||
| 09/26/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $17.93 | General |
| Category: NEUROSCIENCE | ||||||
| 09/19/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $24.72 | General |
| Category: NEUROSCIENCE | ||||||
| 09/18/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $16.79 | General |
| Category: PSYCHIATRY | ||||||
| 09/11/2024 | Alkermes, Inc. | VIVITROL (Drug) | Food and Beverage | In-kind items and services | $17.14 | General |
| Category: CNS | ||||||
| 08/22/2024 | Vanda Pharmaceuticals Inc. | FANAPT (Drug) | Food and Beverage | In-kind items and services | $23.02 | General |
| Category: SCHIZOPHRENIA | ||||||
| 08/21/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $19.29 | General |
| Category: NEUROSCIENCE | ||||||
| 08/15/2024 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug) | Food and Beverage | In-kind items and services | $30.44 | General |
| Category: Neuroscience | ||||||
| 08/14/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $28.95 | General |
| Category: PSYCHIATRY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 1 | 12 | 13 | $3,900 | $1,190 |
| 2022 | 3 | 35 | 112 | $32,160 | $10,335 |
| 2020 | 1 | 11 | 20 | $4,560 | $827.05 |
All Medicare Procedures & Services
5 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 90792 | Psychiatric diagnostic evaluation with medical services | Facility | 2023 | 12 | 13 | $3,900 | $1,190 | 30.5% |
| 99349 | Established patient home visit, typically 40 minutes | Office | 2022 | 12 | 53 | $15,900 | $4,646 | 29.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 12 | 48 | $12,960 | $4,456 | 34.4% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Facility | 2022 | 11 | 11 | $3,300 | $1,233 | 37.4% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 11 | 20 | $4,560 | $827.05 | 18.1% |
About Molly Willis
Molly Willis is a Registered Nurse healthcare provider based in San Diego, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/30/2014. The National Provider Identifier (NPI) number assigned to this provider is 1275921264.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Molly Willis has received a total of $4,171 in payments from pharmaceutical and medical device companies, with $1,284 received in 2024. These payments were reported across 203 transactions from 13 companies. The most common payment nature is "Food and Beverage" ($4,171).
As a Medicare-enrolled provider, Willis has provided services to 58 Medicare beneficiaries, totaling 145 services with total Medicare billing of $12,353. Data is available for 3 years (2020–2023), covering 5 distinct procedure/service records.
Practice Information
- Specialty Registered Nurse
- Other Specialties Psychiatric/Mental Health
- Location San Diego, CA
- Active Since 12/30/2014
- Last Updated 12/13/2016
- Taxonomy Code 163W00000X
- Entity Type Individual
- NPI Number 1275921264
Products in Payments
- CAPLYTA (Drug) $727.09
- INGREZZA (Drug) $440.71
- PERSERIS (Drug) $423.46
- ARISTADA (Drug) $360.65
- INVEGA SUSTENNA (Drug) $347.63
- REXULTI (Drug) $327.81
- UZEDY (Drug) $211.13
- SPRAVATO (Drug) $195.38
- VRAYLAR (Drug) $181.23
- ABILIFY MAINTENA (Drug) $179.63
- AUSTEDO (Drug) $165.51
- HETLIOZ (Drug) $133.96
- ABILIFY ASIMTUFII (Drug) $109.61
- VIVITROL (Drug) $106.75
- FANAPT (Drug) $86.99
- Austedo XR (Drug) $47.64
- Vivitrol (Drug) $32.64
- COBENFY (Drug) $14.07
- QUVIVIQ (Drug) $13.44
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Registered Nurse Doctors in San Diego
Angelina Collins, Np, NP
Registered Nurse — Payments: $242,161
Mr. Andrew Biegner, Crna, CRNA
Registered Nurse — Payments: $45,451
Jonathan Igo, Fnp-C, FNP-C
Registered Nurse — Payments: $12,362
Shalaine Corbilla, Dnp, Fnp-Bc, DNP, FNP-BC
Registered Nurse — Payments: $11,676
Mr. Kelvin Poon
Registered Nurse — Payments: $8,808
Rona Hausser, Pmhnp-Bc, PMHNP-BC
Registered Nurse — Payments: $6,894